Expand all sections

Golimumab

Extended indication Golimumab-lvtc in combination with methotrexate for treatment of moderate to severe active rheumatoi
Therapeutic value No estimate possible yet
Registration phase Registration application pending

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information